SCHEMBL5569659

SCHEMBL5569659

CCOC(=O)N1C(=O)C2CC=CCC2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
LMNA P02545 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
ATM Q13315 2/20 0.42
ALDH1A1 P00352 5/20 0.41
TSHR P16473 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TP53 P04637 1/20 0.40
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
BCHE P06276 1/20 0.39
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18485469 0.88 LMNA (0.40) KMT2ALMNANPSR1ATMALDH1A1
SCHEMBL18485387 0.82 ALDH1A1 (0.61) KMT2ALMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL18485465 0.81 GAA (0.47) KMT2ALMNANPSR1ATMALDH1A1
SCHEMBL11583929 0.81 KMT2A (0.33) KMT2AATMALDH1A1TSHRL3MBTL1
SCHEMBL6930133 0.80 TSHR (0.37) LMNANPSR1ATMALDH1A1TSHR
SCHEMBL18485421 0.80 KMT2A (0.45) KMT2ALMNAATMALDH1A1TSHR
SCHEMBL18485466 0.78 LMNA (0.45) KMT2ALMNANPSR1ATMALDH1A1
SCHEMBL6831925 0.77 BCHE (0.41) KMT2ALMNANPSR1ALDH1A1TSHR
SCHEMBL18485452 0.75 LMNA (0.42) KMT2ALMNANPSR1ATMALDH1A1
SCHEMBL13169805 0.75 CA9 (0.44) KMT2ALMNANPSR1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170114339-A1 Inactivation Method THERMO FISHER SCIENTIFIC BALTICS UAB (LT) 2017-04-27 US claimed
EP-1806400-B1 Inactivation method FERMENTAS UAB (LT) 2013-03-13 EP claimed
US-20070224611-A1 Inactivation method FERMENTAS UAB 2007-09-27 US claimed
EP-1806400-A2 Inactivation method Fermentas UAB (LT) 2007-07-11 EP claimed
EP-3186374-A1 REVERSIBLY INACTIVATED THERMOSTABLE REVERSE TRANSCRIPTASES, COMPOSITIONS AND METHODS FOR USE Life Technologies Corporation (US) 2017-07-05 EP disclosed
US-20170117588-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117588-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117588-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2017-04-27 US disclosed
US-20170114339-A1 Inactivation Method THERMO FISHER SCIENTIFIC BALTICS UAB (LT) 2017-04-27 US disclosed
EP-3131153-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE Sumitomo Seika Chemicals Co., Ltd. (JP) 2017-02-15 EP disclosed
EP-3131153-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE Sumitomo Seika Chemicals Co., Ltd. (JP) 2017-02-15 EP disclosed
US-20160264950-A1 REVERSIBLY INACTIVATED THERMOSTABLE REVERSE TRANSCRIPTASES, COMPOSITIONS AND METHODS FOR USE Life Technologies Corporation 2016-09-15 US disclosed
WO-2016033116-A1 REVERSIBLY INACTIVATED THERMOSTABLE REVERSE TRANSCRIPTASES, COMPOSITIONS AND METHODS FOR USE Life Technologies Corporation (US) 2016-03-03 WO disclosed
US-9273304-B2 Inactivation method THERMO FISHER SCIENTIFIC BALTICS UAB (LT) 2016-03-01 US disclosed
EP-1806400-B1 Inactivation method FERMENTAS UAB (LT) 2013-03-13 EP disclosed
US-20070224611-A1 Inactivation method FERMENTAS UAB 2007-09-27 US disclosed
EP-1806400-A2 Inactivation method Fermentas UAB (LT) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070224611-A1 Inactivation method TREH, UNG, NOTUM KMT2A 1982/4885LMNA 3330/4885NPSR1 4190/4885
US-20170114339-A1 Inactivation Method TREH, UNG, NOTUM KMT2A 1982/4885LMNA 3330/4885NPSR1 4190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.